SCHEMBL25874298

SCHEMBL25874298

O=CCC1CCN(c2cc(C(F)(F)F)ccc2C=O)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 5/20 0.45
▸ LMNA P02545 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ KMT2A Q03164 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LIPG Q9Y5X9 4/20 0.39
▸ LPL P06858 2/20 0.39
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ NOTUM Q6P988 2/20 0.36
▸ GRM2 Q14416 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19608835 0.84 LMNA (0.43) FFAR4LMNASMN1; SMN2KMT2AMAPT
SCHEMBL18914323 0.83 MAPT (0.57) FFAR4LMNASMN1; SMN2KMT2AMAPT
SCHEMBL29417758 0.81 SMN1; SMN2 (0.50) LMNASMN1; SMN2KMT2AMAPTMEN1
SCHEMBL15101008 0.81 SMN1; SMN2 (0.50) LMNASMN1; SMN2KMT2AMAPTMEN1
SCHEMBL18701232 0.81 NOTUM (0.54) FFAR4LMNASMN1; SMN2MAPTCYP1A2
SCHEMBL19582507 0.79 SMN1; SMN2 (0.49) LMNASMN1; SMN2KMT2AMAPTMEN1
SCHEMBL20794008 0.79 LMNA (0.45) FFAR4LMNASMN1; SMN2KMT2AMAPT
SCHEMBL20566963 0.79 HRH3 (0.56) FFAR4LMNASMN1; SMN2ALDH1A1HRH3
SCHEMBL28615760 0.79 GRM2 (0.45) FFAR4LMNASMN1; SMN2KMT2AMAPT
SCHEMBL18064748 0.78 PIM1 (0.42) LMNASMN1; SMN2KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578545-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUNDS MITSUBISHI TANABE PHARMA CORP (JP) 2023-07-26 — — EP disclosed
Send feedback